相关实验视频

Updated: Mar 1, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

探索类风湿性关节炎和2型糖尿病之间的共享基因特征及其对生物信息学分析药物重新定位的影响

Xiaochao Qu¹, Xuemei Zuo¹, Hong Du¹

¹Laboratory of Molecular and Statistical Genetics and Hunan Provincial Key Laboratory of Animal Intestinal Function and Regulation, College of Life Sciences, Hunan Normal University, Changsha, China.

|February 27, 2026

概括

类风湿性关节炎 (RA) 和2型糖尿病 (T2DM) 分享由中性粒细胞驱动的炎症途径. 向与中性粒细胞相关的基因可能为RA相关的T2DM提供新的治疗方法.

科学领域:

免疫学免疫学免疫学
基因组学就是基因组学.
计算生物学计算生物学

背景情况:

类风湿性关节炎 (RA) 和2型糖尿病 (T2DM) 是慢性炎症性疾病,具有已确定的病原性联系.
驱动RA相关T2DM的共享分子机制尚不完全理解,阻碍了有效的治疗开发.

研究的目的:

通过转录和生物信息学分析,阐明RA和T2DM之间的共同分子机制.
确定RA相关T2DM的潜在治疗点和诊断生物标志物.

主要方法:

下载并分析了RA和T2DM的RNA表达特征数据集.
确定了常见的差异表达基因,构建了蛋白质-蛋白质相互作用网络,并进行了基因丰富和免疫微环境分析.
使用的接收器操作特征曲线分析用于诊断评估和分子对接用于药物基因相互作用预测.

主要成果:

确定了352个常见的差异表达基因,主要涉及免疫调节.
确认了13个关键基因,其中10个被确定为与中性粒细胞相关的,涉及中性粒细胞在RA-T2DM病变发生过程中.
发现中性粒细胞驱动的炎症和相关基因加剧胰岛素抵抗,可能导致RA患者T2DM发病.

结论:

中性粒细胞驱动的炎症反应和相关基因显著促进RA患者T2DM的进展.
确定了与中性粒细胞相关的特定基因和途径作为潜在的治疗点.
现在,PD-169316已成为联合RA和T2DM治疗的潜在免疫治疗剂.

关键词:

这是一种炎症炎症炎症炎症.分子对接的分子对接.作为一个中性粒细胞.类风湿性关节炎类风湿性关节炎转录组分析转录组分析 2型糖尿病是什么?

更多相关视频

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq

Published on: April 19, 2013

相关概念视频

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...